Dementia Care Research and Psychosocial Factors

科学分野:

• Cardiology
• Neurology
• Medical Technology

背景:

• Alzheimer's disease (AD) prevalence is rising rapidly in low and middle-income countries (LMIC).
• AD pharmacotherapy carries cardiovascular (CV) risks, necessitating pre-treatment CV health evaluation.
• Electrocardiograms (EKG) are crucial for assessing CV health, but access is limited in remote LMIC settings.

研究 の 目的:

• To compare the accuracy of two portable EKG devices against a standard 12-lead EKG.
• To evaluate the feasibility of using portable EKGs for AD pharmacotherapy decision-making in LMIC.

主な方法:

• One hundred participants from a Brazilian cohort were assessed using a 12-lead EKG.
• Portable EKG devices (KardiaMobile 6L and Samsung Watch Active 2) were used for comparison.
• Statistical analyses included Shapiro-Wilk, Pearson's correlation, and Spearman's correlation tests.

主要な成果:

• No significant statistical differences were found between devices for QTc, PRi, and HR.
• KardiaMobile 6L showed stronger correlations for PRi and QTc intervals.
• Samsung Watch Active 2 demonstrated a stronger correlation for heart rate (HR).

結論:

• Portable EKG devices are a promising, accessible, and accurate technology for evaluating cardiovascular health in AD patients.
• These devices can facilitate faster and more immediate decision-making in remote outpatient settings.
• Further studies are needed to confirm the utility of portable EKGs in managing AD pharmacotherapy.